Free State TB Information

Slides:



Advertisements
Similar presentations
DOTS/ DOTS PLUS IMPLEMENTATION AND INTEGRATION Vaira Leimane State Centre of Tuberculosis and Lung Diseases of Latvia Paris, October, 28.
Advertisements

Evidence based use of Stats SA data for implementation of HIV&AIDS Program Ms Y.Tsibolane FS DoH, HIV and AIDS Program Date: October 2013.
Overview of current case and treatment outcome definitions Malgosia Grzemska TB Operations and Coordination Stop TB Department Consultation Impact of WHO-endorsed.
Accelerating PMDT scale up in Ethiopia
TB Seminar 2014 Agenda and issues in NTP M&E System ARUN GAUTAM, CHIEF, PME SECTION, NTC.
World Tuberculosis Day 2015 The TB situation in 2013: Findings from the joint TB surveillance and monitoring report by ECDC and the WHO Regional Office.
Dr R.Reesaul Chest Physician Chest Clinic P. D`or Hospital
Monitoring and Evaluation Frameworks Kyiv, Ukraine May 23, 2006 MEASURE Evaluation.
Monitoring and Evaluation: Tuberculosis Control Programs
Monitoring and Evaluation: A Review of Terms. Goals To provide better treatment for people with tuberculosis in Country X To achieve a treatment success.
Monitoring and Evaluation Frameworks   What is an M&E Framework?   Why do we use M&E Frameworks?   How do we develop M&E Frameworks? MEASURE Evaluation.
COUNTRY XEPERIENCE AND RESPONSE TO MDR AND XDR TUBERCULOSIS PRESENTED AT THE WHO TB/HIV PLANNING MEETING, ADDIS ABBABA, 11-12, NOVEMBER 2008 BY MS GUGU.
World Tuberculosis Day 2014 The TB situation in 2012: Findings from the joint TB surveillance and monitoring report by ECDC and the WHO Regional Office.
Health Information System “ Consumers’ perspective” Gunnar Bjune March 2013
Revised National Tuberculosis Control Programme (RNTCP)
Status of Revised National Tuberculosis Control Program (RNTCP) in India Dr Jitendra.
Health Information System “ Consumers’ perspective” Gunnar Bjune March 2014
Partnerships to Prevent, Find and Treat TB/DRTB and HIV 12 October 2010 Prof Harry Hausler, Director.
MDR-TB: a fight we cannot afford to lose! Alexander Golubkov, MD, MPH Senior TB Technical Advisor.
DRUG-RESISTANT TB in SOUTH AFRICA: Issues & Response _ ______ _____ _ ______ _____ ___ __ __ __ __ __ _______ ___ ________ ___ _______ _________ __ _____.
NOTIFIED TUBERCULOSIS CASES IN LITHUANIA New cases and relapses (abs.n.)
Outcomes among patients treated for tuberculosis in Limpopo Province, South Africa, Mmakgotso Pilane, Lazarus Kuonza, Eric Maimela.
Progress of the Singapore TB Elimination Programme (STEP)
NATIONAL TB 2012 INDICATOR ANALYSIS REPORT Presented by: Sandile Ginindza Lugogo Sun Hotel 05 th -7 th June 2013 Ministry of Health NTCP.
Health Organization The Challenges Facing Tuberculosis Control Blantyre Hospital, Malawi: TB Division, 3 patients per bed.
Public Health. TB-DOTS program Government commitment Case detection by DSSM among symptomatic patients self-reporting to health services Standard short-course.
Tuberculosis control in Suriname Situational analysis.
PERSPECTIVES FROM THE FIELD DR LYDIA MUNGHERERA TASO (The Aids Support Organisation) UGANDA REVERSING THE TIDE OF TB.
HEALTH PROMOTING SCHOOLS CONFERENCE Promoting health and wellness through schools Ms. L.A TLALI.
Scale up TB/HIV activities in Asia Pacific 8-9Aug09 1 TB/HIV collaborative activities in Thailand Sriprapa Nateniyom, M.D. TB Bureau, Department of Disease.
1 Identifying Contribution of Community-based DOTS in Treatment Outcome of TB Patients in Four Provinces of Afghanistan Qader, Ghulam MD, DPH, MPH Senior.
SUMMARY OF IMPLEMENTATION RESULTS TB Project Round 1 Strengthening access to WHO Standard TB Care and Services for Marginalized Population, Cross-border.
Measures to Decrease TB Prevalence in the Barents Region Andrey O. Maryandyshev Elena I. Nikishova Dmitry V. Perkhin.
FREE STATE NATIONAL NONPROFIT ORGANISATIONS (NPO) SUMMIT: PRESENTATION OF PROVINCIAL REPORT AUGUST 2012 BIRCHWOOD CONFERENCE CENTRE 1.
Taipei, June Content  Introduction about Vietnam’s Programmatic Management of Drug resistant Tuberculosis (PMDT) and drug resistant tuberculosis.
Thailand experience in implementing collaborative HIV/TB activities Anupong Chitwarakorn, MD Ministry of Public Health, Thailand TB/HIV Satellite symposium.
TB/ HIV CONTROL AND MANAGEMENT IN SOUTH AFRICA
TUBERCULOSIS IN JAPAN ANNUAL REPORT – 2016.
Monitoring and Evaluation Frameworks
World Tuberculosis Day 2013
World Tuberculosis Day 2014
Fifth Pacific Stop TB meeting Fiji Islands, May 4-7, 2010
TB Control in PHC network and Partners Coordination in Cambodia
RNTCP implementation status Population (in million)
World Tuberculosis Day 2015
اهمیت سل در چیست؟ حدود یک سوم جمعیت جهان(2 میلیارد نفر)با میکروب سل آلوده شده اند سالانه 9 میلیون نفر به سل فعال مبتلا می شوند هر ساله 1/5 تا 2 میلیون.
Common Messaging Platform
Tuberculosis situation in the EU/EEA, 2016
Nino Mdivani NTP of Georgia
Key issues in DOTS implementation
World Tuberculosis Day 2014
Maternal Mortality in the Free State
Indian Scenario HIV Situation TB Situation
Buhera District.
TB epidemiological situation in Kyrgyzstan
New Hampshire Training Cohort
Success and failure in TB surveillance in Hungary
TB/HIV COLLABORATION IN UGANDA
Goal Objectives Expected Outcomes
DOTS IMPACT TO TUBERCULOSIS IN LITHUANIA
National Tuberculosis Control Program in Vietnam
EXERCISE 11: Computing and Analyzing Program Indicators
TB epidemiology in Bulgaria
Country presentation Dr.Vija Riekstina National TB registry
The STOP TB Strategy – 2009 VISION: A TB-free world
Tuberculosis situation in the EU/EEA, 2017
Tuberculosis situation in the EU/EEA, 2017
DSD and TB/HIV services in Zimbabwe
Tuberculosis situation in the EU/EEA, 2017
The IAS TB/HIV Research Prizes are awarded to:
Presentation transcript:

Free State TB Information 17 August 2011 1

Outline Free State Tuberculosis Incidence Treatment Outcomes Direct Observed Treatment (DOT) Drug Resistant Tuberculosis

24 372 Number of TB cases reported 2010 Fezile Dabi Lejweleputswa 3549 6679 Fezile Dabi 3549 Thabo Mofutsanyana 4748 Xhariep 1445 Motheo 7951

Districts and Free State Population for province MID-YEAR 2011 Districts and Free State Data Element Total FEZILE DABI Total population 503 943 LEJWELEPUTSWA 694 510 MOTHEO 818 954 THABO MOFUTSANYANA 769 762 XHARIEP 143 200 2 930 369

Tuberculosis Incidence In Free State TUBERCULOSIS CASE FINDING Districts and Free State Total Tuberculosis Cases Diagnosed & Treated Number of All TB Incidence all case Per 100,000 population FEZILE DABI 3,601 720 LEJWELEPUTSWA 6,683 963 MOTHEO 7,947 977 THABO MOFUTSANYANA 4,748 619 XHARIEP 1,441 1011 FREE STATE 24,420 837

Tuberculosis Positive Outcome In Free State Tuberculosis Positive Outcomes Total New Smear + Districts & Free State New Sputum Smear Cure Rate Completed Treatment Success   N % FEZILE DABI 1,073 71% 85 6% 1,158 77% 1,509 LEJWELEPUTSWA 1,392 69% 109 5% 1,501 74% 2,032 MOTHEO 1,607 68% 169 7% 1,776 75% 2,378 THABO MOFUTSANYANA 1,650 58 3% 1,708 2,207 XHARIEP 300 79% 18 318 84% 379 FREE STATE 6,022 439 6,461 76% 8,505

Negative Outcome In Free State Districts & Free State Negative Treatment Outcome Total New Smear + Died Defaulted N % FEZILE DABI 190 13% 52 3% 1,509 LEJWELEPUTSWA 233 12% 134 7% 2,032 MOTHEO 239 10% 145 6% 2,378 THABO MOFUTSANYANA 304 14% 55 2,207 XHARIEP 24 13 379 FREE STATE 990 399 5% 8,505

Direct Observe Treatment (DOT) District / Province Type of DOT Facility DOT Community Self-supervised N % FEZILE DABI 489 30% 933 56% 234 14% LEJWELEPUTSWA 1,376 42% 1,584 48% 315 10% MOTHEO 1,596 33% 1,832 37% 1,462 THABO MOFUTSANYANA 882 1,635 62% 125 5% XHARIEP 167 63% 38 60 23% FREE STATE DOT coverage 83% No DOT 17%

Drug Resistant Tuberculosis Currently 265 Multi Drug Resistant (MDR) Tuberculosis and 7 Extensively Drug Resistant (XDR) Tuberculosis patients are on treatment.

TB/HIV INTEGRATION Percentage of TB/HIV patients on CPT increased from 77% to 80,4% Low percentage of TB/HIV patients access ART.Q1 at 24,6% Q 2 at 56% Increase in HIV positive patients initiated on IPT from 7907 in Q1 and 8523 in Q2

CHALLENGES Employer support Family support Treatment interruption Defaulting Stigma Psycho social determinants

THANK YOU